Meningitis vaccine recommended for three groups of young peopleBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7504.1348 (Published 09 June 2005) Cite this as: BMJ 2005;330:1348
- Scott Gottlieb
- New York
The US Centers for Disease Control and Prevention (CDC) has recommended the use of a new vaccine against meningitis for three groups of young people: children between 11 and 12 years old, students entering high school, and new students at college who will be living in student accommodation. The American Academy of Pediatrics also released similar recommendations.
The new meningitis vaccine, MCV4, was approved in January by the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial